Carregant...
Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers
Esophagogastric cancers (EGCa) are a leading cause of cancer related mortality worldwide. It has been recognized that they represent heterogenous diseases based on histology and anatomy. However, it is also increasingly evident that these are diverse malignancies based on genetic alterations, and th...
Guardat en:
| Publicat a: | J Gastrointest Oncol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056259/ https://ncbi.nlm.nih.gov/pubmed/27747090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.08.13 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|